{"id":"indinavir-idv","safety":{"commonSideEffects":[{"rate":"10-15","effect":"Nephrolithiasis (kidney stones)"},{"rate":"20-30","effect":"Gastrointestinal disturbances (nausea, diarrhea)"},{"rate":"10-15","effect":"Headache"},{"rate":"10-20","effect":"Hyperbilirubinemia"},{"rate":null,"effect":"Lipodystrophy"},{"rate":null,"effect":"Hyperglycemia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Indinavir binds to the active site of HIV protease, a viral enzyme essential for processing precursor proteins into functional structural and enzymatic proteins. By inhibiting this protease, the drug prevents the formation of mature, infectious viral particles, thereby reducing viral replication and slowing disease progression in HIV-infected patients.","oneSentence":"Indinavir is a protease inhibitor that blocks HIV protease, preventing the cleavage of viral polyproteins and maturation of infectious HIV particles.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:48:26.031Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"HIV-1 infection"}]},"trialDetails":[{"nctId":"NCT02016924","phase":"PHASE2, PHASE3","title":"Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gilead Sciences","startDate":"2014-01-16","conditions":"Acquired Immune Deficiency Syndrome (AIDS), HIV Infections","enrollment":133},{"nctId":"NCT02302547","phase":"PHASE3","title":"Trial to Evaluate the Interest of a Reductive Anti Retroviral Strategy Using Dual Therapy Inspite of Triple Therapy","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2014-12","conditions":"HIV","enrollment":224},{"nctId":"NCT00042289","phase":"","title":"Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2003-06-09","conditions":"HIV Infections","enrollment":1578},{"nctId":"NCT05502341","phase":"PHASE2, PHASE3","title":"Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gilead Sciences","startDate":"2022-08-16","conditions":"HIV-1-infection","enrollment":689},{"nctId":"NCT00476606","phase":"","title":"A Prospective Cohort of Children With HIV Infection","status":"COMPLETED","sponsor":"The HIV Netherlands Australia Thailand Research Collaboration","startDate":"2003-03","conditions":"HIV Infections","enrollment":500},{"nctId":"NCT00003008","phase":"PHASE2","title":"Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma","status":"COMPLETED","sponsor":"Eastern Cooperative Oncology Group","startDate":"1997-12-15","conditions":"Sarcoma","enrollment":33},{"nctId":"NCT00039741","phase":"PHASE2, PHASE3","title":"Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2002-08","conditions":"HIV Infections","enrollment":266},{"nctId":"NCT00000841","phase":"PHASE3","title":"A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":1750},{"nctId":"NCT00000848","phase":"PHASE2","title":"The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One Year","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":144},{"nctId":"NCT00000892","phase":"NA","title":"A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":300},{"nctId":"NCT00001083","phase":"PHASE2","title":"Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":240},{"nctId":"NCT00001084","phase":"PHASE2","title":"A Study of Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected Patients","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":500},{"nctId":"NCT00001095","phase":"PHASE2","title":"A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":94},{"nctId":"NCT00012519","phase":"PHASE1, PHASE2","title":"Ritonavir and Indinavir in Children Failing Other Anti-HIV Treatment","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":29},{"nctId":"NCT00001058","phase":"PHASE2","title":"A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"Mycobacterium Avium-intracellulare Infection, HIV Infections","enrollment":246},{"nctId":"NCT00001086","phase":"PHASE2","title":"A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":300},{"nctId":"NCT00027339","phase":"PHASE2","title":"Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":53},{"nctId":"NCT00039975","phase":"PHASE1","title":"Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections, Cardiovascular Diseases, Hypertension","enrollment":32},{"nctId":"NCT00006339","phase":"PHASE2","title":"Safety and Effectiveness of an Anti-HIV Drug Combination With and Without Hydroxyurea in Patients With Early HIV Infection","status":"WITHDRAWN","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":""},{"nctId":"NCT00005762","phase":"NA","title":"Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2001-03","conditions":"HIV Infections","enrollment":90},{"nctId":"NCT00001133","phase":"PHASE1","title":"Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":50},{"nctId":"NCT00000877","phase":"PHASE1","title":"Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative Adults","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":31},{"nctId":"NCT00000859","phase":"NA","title":"A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":1300},{"nctId":"NCT00000914","phase":"NA","title":"A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":800},{"nctId":"NCT00000916","phase":"PHASE2","title":"A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their Blood","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":399},{"nctId":"NCT00000912","phase":"PHASE2","title":"A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":475},{"nctId":"NCT00000896","phase":"NA","title":"A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":24},{"nctId":"NCT00000944","phase":"PHASE1","title":"A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their Infants","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections, Pregnancy","enrollment":24},{"nctId":"NCT00000850","phase":"PHASE2","title":"The Effectiveness of GM-CSF in HIV-Positive Patients Who Are Also Receiving Anti-HIV Therapy","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":108},{"nctId":"NCT00000885","phase":"PHASE2","title":"Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":440},{"nctId":"NCT00000861","phase":"NA","title":"The Addition of Indinavir to Anti-HIV Treatment in HIV-Infected Patients","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":1900},{"nctId":"NCT00000901","phase":"PHASE1","title":"Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":24},{"nctId":"NCT01232361","phase":"","title":"IMPAACT P1080: Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and Adolescents","status":"COMPLETED","sponsor":"International Maternal Pediatric Adolescent AIDS Clinical Trials Group","startDate":"2010-10-08","conditions":"ADHD, HIV","enrollment":127},{"nctId":"NCT00411996","phase":"PHASE1, PHASE2","title":"The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin","status":"COMPLETED","sponsor":"The HIV Netherlands Australia Thailand Research Collaboration","startDate":"2006-12","conditions":"HIV Infections, Tuberculosis","enrollment":20},{"nctId":"NCT00307502","phase":"PHASE1","title":"Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV","status":"COMPLETED","sponsor":"Germans Trias i Pujol Hospital","startDate":"2005-01","conditions":"HIV Infections","enrollment":675},{"nctId":"NCT02556268","phase":"PHASE1","title":"Interaction With HIV Antiretroviral Agents","status":"COMPLETED","sponsor":"Bayer","startDate":"2016-02-23","conditions":"HIV-DDI","enrollment":40},{"nctId":"NCT00001644","phase":"PHASE1","title":"Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"1997-03-03","conditions":"HIV Infection","enrollment":42},{"nctId":"NCT00050180","phase":"PHASE4","title":"Influence of the MDR1 Genotype on Blood Levels of Indinavir and Saquinavir in Healthy Volunteers","status":"COMPLETED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2002-11-22","conditions":"Healthy, HIV Infections","enrollment":81},{"nctId":"NCT00541463","phase":"PHASE2","title":"A Study of Indinavir Plus Ritonavir Plus Two NRTIs vs. Nelfinavir Plus Two NRTIs in HIV Positive Patients (0639-112)(COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2001-01","conditions":"HIV Infections","enrollment":330},{"nctId":"NCT00000875","phase":"NA","title":"Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":16},{"nctId":"NCT00000804","phase":"NA","title":"A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113)","status":"WITHDRAWN","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":""},{"nctId":"NCT01067690","phase":"PHASE2","title":"Treatment With Indinavir and Chemotherapy for Advanced Classical Kaposi's Sarcoma","status":"COMPLETED","sponsor":"Barbara Ensoli, MD, PhD","startDate":"2008-06","conditions":"Kaposi's Sarcoma","enrollment":25},{"nctId":"NCT00445146","phase":"PHASE2","title":"Safety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 Infection","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2007-02","conditions":"HIV Infections","enrollment":192},{"nctId":"NCT00477048","phase":"PHASE2","title":"Efficacy and Safety of SQV in Patients Who Have Chronic IDV Nephrotoxicity","status":"COMPLETED","sponsor":"The HIV Netherlands Australia Thailand Research Collaboration","startDate":"2004-05","conditions":"IDV Associated Nephrotoxicity","enrollment":30},{"nctId":"NCT00626301","phase":"PHASE4","title":"Lopinavir/Ritonavir Monotherapy in Children","status":"COMPLETED","sponsor":"The HIV Netherlands Australia Thailand Research Collaboration","startDate":"2007-11","conditions":"HIV Infections","enrollment":40},{"nctId":"NCT02300623","phase":"PHASE4","title":"Intermittent ART in Primary HIV Infection","status":"COMPLETED","sponsor":"Juan A. Arnaiz","startDate":"2000-03","conditions":"HIV","enrollment":12},{"nctId":"NCT00000922","phase":"NA","title":"A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":1710},{"nctId":"NCT00148785","phase":"PHASE4","title":"A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and Amprenavir","status":"COMPLETED","sponsor":"Emory University","startDate":"2005-07","conditions":"HIV Infections","enrollment":15},{"nctId":"NCT00000874","phase":"","title":"A Pilot Study of the Short-Term Effects of Antiretroviral Management Based on Plasma Genotypic Antiretroviral Resistance Testing (GART) Compared With Antiretroviral Management Without Plasma GART","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"1997-08","conditions":"HIV Infections","enrollment":148},{"nctId":"NCT00006154","phase":"PHASE3","title":"A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":165},{"nctId":"NCT00637637","phase":"PHASE2","title":"External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases","status":"UNKNOWN","sponsor":"Oncology Institute of Southern Switzerland","startDate":"2007-09","conditions":"Cancer","enrollment":60},{"nctId":"NCT00000882","phase":"PHASE2","title":"Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":300},{"nctId":"NCT00016601","phase":"NA","title":"Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected Women","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2001-06","conditions":"HIV Infections","enrollment":76},{"nctId":"NCT00001566","phase":"PHASE2","title":"A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"1996-12","conditions":"Ewing's Sarcoma, Rhabdomyosarcoma","enrollment":42},{"nctId":"NCT00000919","phase":"NA","title":"A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":900},{"nctId":"NCT00000903","phase":"PHASE3","title":"Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":444},{"nctId":"NCT00000870","phase":"PHASE2","title":"A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":200},{"nctId":"NCT00000918","phase":"PHASE2","title":"A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":300},{"nctId":"NCT00000923","phase":"NA","title":"Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":110},{"nctId":"NCT00192660","phase":"PHASE4","title":"HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)","status":"COMPLETED","sponsor":"Kirby Institute","startDate":"2003-02","conditions":"HIV-Associated Lipodystrophy Syndrome, Cardiovascular Disease","enrollment":80},{"nctId":"NCT00002371","phase":"PHASE3","title":"The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"1996-06","conditions":"HIV Infections","enrollment":80},{"nctId":"NCT00001119","phase":"NA","title":"Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"1999-10","conditions":"HIV Infections","enrollment":288},{"nctId":"NCT00006443","phase":"NA","title":"Effectiveness of Anti-HIV Drugs in Patients Who Have Not Received Previous Anti-HIV Drugs During Different Stages of HIV Infection","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":24},{"nctId":"NCT00197639","phase":"","title":"Pharmacokinetic Study of Indinavir Drug Levels When Boosted With Ritonavir in Thailand","status":"COMPLETED","sponsor":"Harvard School of Public Health (HSPH)","startDate":"2006-09","conditions":"HIV Infection","enrollment":19},{"nctId":"NCT00259727","phase":"","title":"The Study of HIV Protease Inhibitors and Their Effects on Glucose Metabolism","status":"COMPLETED","sponsor":"US Department of Veterans Affairs","startDate":"2006-01","conditions":"Diabetes, HIV Infections, Insulin Resistance","enrollment":80},{"nctId":"NCT00002223","phase":"NA","title":"A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients","status":"COMPLETED","sponsor":"Abbott","startDate":"","conditions":"HIV Infections","enrollment":""},{"nctId":"NCT00158405","phase":"PHASE3","title":"Randomised Trial of Structured Treatment Interruption of HAART in HIV-Infected Adults in Abidjan (ANRS 1269 TRIVACAN)","status":"COMPLETED","sponsor":"French National Agency for Research on AIDS and Viral Hepatitis","startDate":"2002-12","conditions":"HIV Infections","enrollment":840},{"nctId":"NCT00362310","phase":"PHASE2","title":"Treatment of Classical Non-HIV-Related Kaposi's Sarcoma With the Antiviral Drug Indinavir","status":"COMPLETED","sponsor":"Istituto Superiore di Sanità","startDate":"2003-06","conditions":"Classical Kaposi's Sarcoma","enrollment":28},{"nctId":"NCT00001353","phase":"","title":"Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin Pairs","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"1993-03","conditions":"Acquired Immunodeficiency Syndrome, HIV Infection","enrollment":24},{"nctId":"NCT00001443","phase":"PHASE1","title":"A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"1995-07","conditions":"Acquired Immunodeficiency Syndrome, HIV Infections","enrollment":63},{"nctId":"NCT00011635","phase":"PHASE1","title":"The Effect of Milk Thistle on the Pharmacokinetics of Indinavir","status":"COMPLETED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2001-02","conditions":"HIV Infection, Healthy","enrollment":20},{"nctId":"NCT00002168","phase":"NA","title":"A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"","conditions":"HIV Infections","enrollment":200},{"nctId":"NCT00002369","phase":"NA","title":"A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"","conditions":"HIV Infections","enrollment":200},{"nctId":"NCT00120783","phase":"PHASE2","title":"Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug Resistance","status":"TERMINATED","sponsor":"French National Agency for Research on AIDS and Viral Hepatitis","startDate":"2002-02","conditions":"HIV Infections","enrollment":40},{"nctId":"NCT00122590","phase":"NA","title":"Evaluation of Therapeutic Drug Monitoring of Protease Inhibitors on Virologic Success and Tolerance of Highly Active Antiretroviral Therapy (HAART)","status":"TERMINATED","sponsor":"French National Agency for Research on AIDS and Viral Hepatitis","startDate":"2002-07","conditions":"HIV Infections","enrollment":115},{"nctId":"NCT00002241","phase":"PHASE2","title":"Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice Daily","status":"UNKNOWN","sponsor":"Merck Sharp & Dohme LLC","startDate":"","conditions":"HIV Infections","enrollment":80},{"nctId":"NCT00002361","phase":"PHASE2","title":"Safety and Effectiveness of an Anti-HIV Drug Combination in HIV-Positive Patients Who Have Failed Previous Treatment With Protease Inhibitors","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"","conditions":"HIV Infections","enrollment":30},{"nctId":"NCT00002208","phase":"PHASE3","title":"A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TC","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"","conditions":"HIV Infections","enrollment":400},{"nctId":"NCT00002452","phase":"PHASE2","title":"A Study on the Safety and Effectiveness of L-756423 Plus Indinavir in HIV-Positive Patients Who Have Previously Taken Indinavir","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"","conditions":"HIV Infections","enrollment":30},{"nctId":"NCT00002379","phase":"PHASE2","title":"The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"","conditions":"HIV Infections","enrollment":100},{"nctId":"NCT00002407","phase":"NA","title":"A Study of Three Drug Combination Therapies in HIV-Infected Patients Who Have Never Been Treated With Anti-HIV Drugs","status":"COMPLETED","sponsor":"Weill Medical College of Cornell University","startDate":"","conditions":"HIV Infections","enrollment":""},{"nctId":"NCT00002451","phase":"PHASE2","title":"Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs","status":"UNKNOWN","sponsor":"Merck Sharp & Dohme LLC","startDate":"","conditions":"HIV Infections","enrollment":8},{"nctId":"NCT00002410","phase":"PHASE3","title":"A Study of Three Different Anti-HIV Drug Combinations in HIV-Infected Patients","status":"COMPLETED","sponsor":"Dupont Merck","startDate":"","conditions":"HIV Infections","enrollment":""},{"nctId":"NCT00002351","phase":"PHASE1","title":"A Study of L-735,524 in HIV-Positive Children and Adolescents","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"","conditions":"HIV Infections","enrollment":12},{"nctId":"NCT00002442","phase":"PHASE2","title":"A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV Drugs","status":"COMPLETED","sponsor":"Glaxo Wellcome","startDate":"1999-06","conditions":"HIV Infections","enrollment":""},{"nctId":"NCT00005118","phase":"PHASE2","title":"The Safety and Effectiveness of Indinavir Plus Ritonavir Plus Two NRTIs in HIV-Infected Patients Who Need Early Intervention Treatment","status":"UNKNOWN","sponsor":"Merck Sharp & Dohme LLC","startDate":"","conditions":"HIV Infections","enrollment":100},{"nctId":"NCT00002386","phase":"PHASE4","title":"Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"","conditions":"HIV Infections, Hemophilia A","enrollment":55},{"nctId":"NCT00002354","phase":"NA","title":"A Study of Indinavir Sulfate Given Together With Stavudine to HIV-Positive Patients","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"","conditions":"HIV Infections","enrollment":540},{"nctId":"NCT00002376","phase":"PHASE4","title":"The Effectiveness of HIV RNA Viral Load Testing in Determining Treatment Type in HIV-Infected Patients","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"","conditions":"HIV Infections","enrollment":540},{"nctId":"NCT00002424","phase":"PHASE2","title":"A Study to Compare the Safety and Effectiveness of Indinavir Combined With Stavudine and Lamivudine","status":"SUSPENDED","sponsor":"Merck Sharp & Dohme LLC","startDate":"","conditions":"HIV Infections","enrollment":186},{"nctId":"NCT00002179","phase":"PHASE4","title":"The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of Infection","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"","conditions":"HIV Infections","enrollment":200},{"nctId":"NCT00002400","phase":"NA","title":"A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients","status":"COMPLETED","sponsor":"Pharmacia and Upjohn","startDate":"","conditions":"HIV Infections","enrollment":45},{"nctId":"NCT00002236","phase":"NA","title":"A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients","status":"COMPLETED","sponsor":"Pharmacia and Upjohn","startDate":"","conditions":"HIV Infections","enrollment":32},{"nctId":"NCT00002387","phase":"NA","title":"The Safety and Effectiveness of Indinavir Sulfate Plus Efavirenz","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"","conditions":"HIV Infections","enrollment":80},{"nctId":"NCT00002220","phase":"PHASE3","title":"Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"","conditions":"HIV Infections","enrollment":120},{"nctId":"NCT00002423","phase":"PHASE2","title":"A Study to Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include Amprenavir","status":"COMPLETED","sponsor":"Glaxo Wellcome","startDate":"1999-03","conditions":"HIV Infections","enrollment":100},{"nctId":"NCT00002155","phase":"NA","title":"A Six-Month Safety and Antiviral Study in HIV-1 Seropositive, AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cells/mm3 to Evaluate MK-639 Alone Versus Zidovudine (AZT) and 3TC Versus the Combination of MK-639 With AZT/3TC","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"","conditions":"HIV Infections","enrollment":600},{"nctId":"NCT00002202","phase":"PHASE3","title":"A Comparison of 141W94 and Indinavir in HIV-Infected Patients","status":"COMPLETED","sponsor":"Glaxo Wellcome","startDate":"","conditions":"HIV Infections","enrollment":460},{"nctId":"NCT00002393","phase":"PHASE3","title":"A Study of Indinavir Taken With or Without DMP 266","status":"COMPLETED","sponsor":"Dupont Merck","startDate":"","conditions":"HIV Infections","enrollment":300},{"nctId":"NCT00002209","phase":"PHASE1","title":"Safety and Effectiveness of CPI-1189 in HIV-Infected Males on Combination Anti-HIV Drug Therapy","status":"COMPLETED","sponsor":"Centaur Pharmaceuticals","startDate":"","conditions":"AIDS Dementia Complex, HIV Infections","enrollment":48}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":170,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Indinavir (IDV)","genericName":"Indinavir (IDV)","companyName":"French National Agency for Research on AIDS and Viral Hepatitis","companyId":"french-national-agency-for-research-on-aids-and-viral-hepatitis","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Indinavir is a protease inhibitor that blocks HIV protease, preventing the cleavage of viral polyproteins and maturation of infectious HIV particles. Used for HIV-1 infection.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}